María Sánchez-Aguilar

Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II

Luz Ibarra-Lara, María Sánchez-Aguilar, Alicia Sánchez-Mendoza et al. · Molecules · 2016 · 34 citations · Full text

Medicine, Cardiology, Pharmacology +17

Peroxisome proliferator-activated receptors (PPAR) downregulate the expression of pro-inflammatory molecules in an experimental model of myocardial infarction

Luz Ibarra-Lara, María Sánchez-Aguilar, Elizabeth Soria‐Castro et al. · Canadian Journal of Physiology and Pharmacology · 2016 · 29 citations · Full text

Medicine, Cardiology, Pharmacology +17

PPARα stimulation exerts a blood pressure lowering effect through different mechanisms in a time-dependent manner

Luz Ibarra-Lara, Luz Graciela Cervantes-Pérez, Francisca Pérez‐Severiano et al. · European Journal of Pharmacology · 2009 · 25 citations

Medicine, Biochemistry, Pharmacology +14

Extracts of Crataegus oxyacantha and Rosmarinus officinalis Attenuate Ischemic Myocardial Damage by Decreasing Oxidative Stress and Regulating the Production of Cardiac Vasoactive Agents

Raúl Enrique Cuevas-Durán, Juan Carlos Medrano-Rodríguez, María Sánchez-Aguilar et al. · International Journal of Molecular Sciences · 2017 · 25 citations · Full text

Life Sciences, Cardiology, Pharmacology +17

Rosiglitazone, a Ligand to PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow></mml:math>, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation

María Sánchez-Aguilar, Luz Ibarra-Lara, Leonardo del Valle‐Mondragón et al. · PPAR Research · 2019 · 25 citations · Full text

Medicine, Pharmacology, Physiology +17